304 related articles for article (PubMed ID: 15104834)
1. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer.
Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M
J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834
[TBL] [Abstract][Full Text] [Related]
2. Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?
Garuti G; Grossi F; Cellani F; Centinaio G; Colonnelli M; Luerti M
Breast Cancer Res Treat; 2002 Apr; 72(3):245-53. PubMed ID: 12058966
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
[TBL] [Abstract][Full Text] [Related]
5. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S
J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435
[TBL] [Abstract][Full Text] [Related]
6. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
[TBL] [Abstract][Full Text] [Related]
8. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.
Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B
Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen.
Gao WL; Zhang LP; Feng LM
Chin Med J (Engl); 2011 Aug; 124(15):2335-9. PubMed ID: 21933565
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
[TBL] [Abstract][Full Text] [Related]
11. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients.
Giorda G; Crivellari D; Veronesi A; Perin T; Campagnutta E; Carbone A; Scarabelli C
Acta Obstet Gynecol Scand; 2002 Oct; 81(10):975-80. PubMed ID: 12366490
[TBL] [Abstract][Full Text] [Related]
13. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
[TBL] [Abstract][Full Text] [Related]
14. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
15. Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake.
Garuti G; Cellani F; Grossi F; Colonnelli M; Centinaio G; Luerti M
Gynecol Oncol; 2002 Sep; 86(3):323-9. PubMed ID: 12217755
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
Lee M; Piao J; Jeon MJ
Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
[TBL] [Abstract][Full Text] [Related]
17. Comparison of endometrial pathologies collected by hysteroscopy and hysterectomy in postmenopausal breast cancer tamoxifen-treated patients.
Cohen I; Azaria R; Bernheim J; Tepper R; Sharony R; Beyth Y
Eur J Gynaecol Oncol; 2000; 21(4):418-22. PubMed ID: 11055500
[TBL] [Abstract][Full Text] [Related]
18. Sonographic, hysteroscopic, and histologic evaluation of the endometrium in postmenopausal women with breast cancer receiving tamoxifen.
Ceci O; Bettocchi S; Marello F; Nappi L; Chiechi LM; Laricchia L; Masciandaro A
J Am Assoc Gynecol Laparosc; 2000 Feb; 7(1):77-81. PubMed ID: 10648743
[TBL] [Abstract][Full Text] [Related]
19. Hysteroscopic dynamic assessment of the endometrium in patients treated with long-term tamoxifen.
Pérez-Medina T; Salazar FJ; San-Frutos L; Ríos M; Jiménez JS; Troyano J; Cayuela E; Iglesias E
J Minim Invasive Gynecol; 2011; 18(3):349-54. PubMed ID: 21411378
[TBL] [Abstract][Full Text] [Related]
20. Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens.
Garuti G; Mirra M; Luerti M
J Minim Invasive Gynecol; 2006; 13(4):325-30. PubMed ID: 16825075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
